Mark A Huffman

This inventor holds 18 USPTO granted patents and 8 published patent applications, plus 1 CIPO patent and 2 EPO patents, primarily in Enzyme Engineering. Top assignees: Codexis, Inc., Merck + Co., Inc., Merck Sharp + Dohme Corp.. Active years: 1995-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mark A Huffman. Retrieved from https://idiyas.com/inventor/mark-a-huffman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 18 (Patent Applications = 8)

% Patents Active = 94.4

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 2 (Patent Applications = 7)

Average Co-Inventor Count = 4.8

ph-index = 2

Forward Citations = 27(Granted Patents)

Location History:

Scotch Plains, NJ (US) (1995 - 1997)
Edgewater, NJ (US) (2000 - 2001)
Rahway, NJ (US) (2021 - 2023)
Warren, NJ (US) (2009 - 2024)

Company Filing History:

Merck Sharp + Dohme Corp.

patents

Years Active: 1995-2025

Loading Chart...

Areas of Expertise:

Deoxyribose-Phosphate Aldolases

Phosphopentomutase

Nucleoside Phosphorylase

Enzymatic Synthesis

Hydroisoindoline

Titanocene

Stereoselective Process

Carbapenems

Boronic Acid

Inhibitor Compounds

Reagent Stabilization

Asymmetric Synthesis

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12460195 - Engineered deoxyribose-phosphate aldolases (2025-11-04),

2. 12421509 - Engineered phosphopentomutase variant enzymes (2025-09-23),

3. 12110493 - Engineered purine nucleoside phosphorylase variant enzymes (2024-10-08),

4. 12037623 - Enzymatic synthesis of 4'-ethynyl nucleoside analogs (2024-07-16),

5. 11845968 - Engineered deoxyribose-phosphate aldolases (2023-12-19),

6. 11795445 - Engineered phosphopentomutase variant enzymes (2023-10-24),

7. 11274286 - Engineered deoxyribose-phosphate aldolases (2022-03-15),

8. 11162105 - Engineered purine nucleoside phosphorylase variant enzymes (2021-11-02),

9. 11034948 - Engineered phosphopentomutase variant enzymes (2021-06-15),

10. 7875642 - Crystalline forms of an inhibitor of 11-β-hydroxysteroid dehydrogenase type 1 (2011-01-25),

11. 7847095 - Process for 5-[[2(r)-[1(r)-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3(s)-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3h-1.,2,4-triazol-3-one (2010-12-07),

12. 7544815 - Process for making hydroisoindoline tachykinin receptor antagonists (2009-06-09),

13. 6255550 - Stabilization of the reagent dimethyl titanocene (2001-07-03),

14. 6063950 - Process for the preparation of titanocene dichloride (2000-05-16),

15. 6025500 - Stereoselective process for enalapril (2000-02-15),

Title: The Inventor Mark A Huffman: Pioneering Innovations in Warren, NJ

Introduction: Mark A Huffman is a distinguished inventor based in Warren, NJ, known for his groundbreaking contributions to various fields.

Latest Patents: Mark A Huffman holds several patents in the areas of technology, healthcare, and consumer products, showcasing his versatility and ingenuity.

Career Highlights: With a career spanning over two decades, Mark A Huffman has consistently pushed the boundaries of innovation, leading to significant advancements in his respective industries.

Collaborations: Throughout his career, Mark A Huffman has collaborated with leading companies, research institutions, and universities to bring his inventions to life, fostering a culture of creativity and progress.

Conclusion: Mark A Huffman's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors, leaving a lasting impact on the world of technology and beyond.

Profile summary based on public USPTO records.